Clinical Trials Logo

Major Depressive Episode clinical trials

View clinical trials related to Major Depressive Episode.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05301036 Active, not recruiting - Clinical trials for Major Depressive Episode

Personalized Ultrasonic Brain Stimulation for Depression

Start date: July 15, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychological and physiological monitoring. A well-tolerated stimulation protocol will then be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial to evaluate brain target engagement using magnetic resonance imaging.

NCT ID: NCT04854785 Active, not recruiting - Covid19 Clinical Trials

Neuroinflammation in COVID-19 and Depression

Start date: June 14, 2021
Phase:
Study type: Observational

The purpose of this study is to use state of the art brain imaging technology to investigate neuroinflammation in participants with depression after the respiratory symptoms of coronavirus disease 2019 (COVID-19) have passed.

NCT ID: NCT03487926 Active, not recruiting - Clinical trials for Inflammatory Bowel Diseases

Microglial Activation in Inflammatory Bowel Disease

Start date: September 14, 2022
Phase:
Study type: Observational

The purpose of this study is to monitor microglial activation in participants with inflammatory bowel disease (IBD) and investigate the relationship that exists between these patients and their risk of acquiring major depressive episodes (MDE). Patients with both IBD and MDE will be subsequently approached to participate in the study.